The Company's lead platform technology a novel stem cell manufacturing process known as Cymerus has now been successfully validated at a key U.S. biomanufacturing site. have now confirmed this state-of-the-art stem cell manufacturing process is capable of producing MSCs for therapeutic application, consistently, efficiently and economically, in a Good Manufacturing Practice production environment.
http://ift.tt/1803P0V
http://ift.tt/1803P0V
No comments:
Post a Comment